<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xml:lang="EN" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?origin publisher?><?properties no_embargo?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pflugers Arch</journal-id><journal-title>Pflugers Archiv </journal-title><issn pub-type="ppub">0031-6768</issn><issn pub-type="epub">1432-2013</issn><publisher><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">690</article-id><article-id pub-id-type="doi">10.1007/s00424-009-0690-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Ion Channels, Receptors and Transporters</subject></subj-group></article-categories><title-group><article-title>The two-pore channel TPCN2 mediates NAADP-dependent Ca<sup>2+</sup>-release from lysosomal stores</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Zong</surname><given-names>Xiangang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schieder</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cuny</surname><given-names>Hartmut</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fenske</surname><given-names>Stefanie</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gruner</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>R&#x000f6;tzer</surname><given-names>Katrin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Griesbeck</surname><given-names>Oliver</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Harz</surname><given-names>Hartmann</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Biel</surname><given-names>Martin</given-names></name><address><phone>+49-89-218077654</phone><fax>+49-89-218077326</fax><email>martin.biel@cup.uni-muenchen.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Wahl-Schott</surname><given-names>Christian</given-names></name><address><phone>+49-89-218077654</phone><fax>+49-89-218077326</fax><email>christian.wahl@cup.uni-muenchen.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label>Center for Integrated Protein Science CIPS-M and Zentrum f&#x000fc;r Pharmaforschung, Department Pharmazie, Ludwig-Maximilians-Universit&#x000e4;t M&#x000fc;nchen, Butenandtstr. 5-13, 81377 Munich, Germany </aff><aff id="Aff2"><label>2</label>Max Planck Institute of Neurobiology, Martinsried, Germany </aff><aff id="Aff3"><label>3</label>BioImaging Zentrum der Ludwig-Maximilians-Universit&#x000e4;t M&#x000fc;nchen, Munich, Germany </aff><aff id="Aff4"><label>4</label>Department Pharmazie, Pharmakologie f&#x000fc;r Naturwissenschaften, Ludwig-Maximilians-Universit&#x000e4;t M&#x000fc;nchen, Butenandtstr. 5-13, 81377 M&#x000fc;nchen, Germany </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>6</month><year>2009</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2009</year></pub-date><volume>458</volume><issue>5</issue><fpage>891</fpage><lpage>899</lpage><history><date date-type="received"><day>30</day><month>5</month><year>2009</year></date><date date-type="accepted"><day>2</day><month>6</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2009</copyright-statement></permissions><abstract xml:lang="EN"><p>Second messenger-induced Ca<sup>2+</sup>-release from intracellular stores plays a key role in a multitude of physiological processes. In addition to 1,4,5-inositol trisphosphate (IP<sub>3</sub>), Ca<sup>2+</sup>, and cyclic ADP ribose (cADPR) that trigger Ca<sup>2+</sup>-release from the endoplasmatic reticulum (ER), nicotinic acid adenine dinucleotide phosphate (NAADP) has been identified as a cellular metabolite that mediates Ca<sup>2+</sup>-release from lysosomal stores. While NAADP-induced Ca<sup>2+</sup>-release has been found in many tissues and cell types, the molecular identity of the channel(s) conferring this release remained elusive so far. Here, we show that TPCN2, a novel member of the two-pore cation channel family, displays the basic properties of native NAADP-dependent Ca<sup>2+</sup>-release channels. TPCN2 transcripts are widely expressed in the body and encode a lysosomal protein forming homomers. TPCN2 mediates intracellular Ca<sup>2+</sup>-release after activation with low-nanomolar concentrations of NAADP while it is desensitized by micromolar concentrations of this second messenger and is insensitive to the NAADP analog nicotinamide adenine dinucleotide phosphate (NADP). Furthermore, TPCN2-mediated Ca<sup>2+</sup>-release is almost completely abolished when the capacity of lysosomes for storing Ca<sup>2+</sup> is pharmacologically blocked. By contrast, TPCN2-specific Ca<sup>2+</sup>-release is unaffected by emptying ER-based Ca<sup>2+</sup> stores. In conclusion, these findings indicate that TPCN2 is a major component of the long-sought lysosomal NAADP-dependent Ca<sup>2+</sup>-release channel.</p><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1007/s00424-009-0690-y) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>TPCN2</kwd><kwd>Two-pore channels</kwd><kwd>NAADP</kwd><kwd>Ca<sup>2+</sup>-release</kwd><kwd>Lysosome</kwd><kwd>Acidic stores</kwd></kwd-group><custom-meta-wrap><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag 2009</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>Ca<sup>2+</sup>-release from intracellular stores is a fundamental cellular process that is involved in the control of numerous physiological functions including muscle contraction, secretion, cell motility, and control of immune response [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Given the diversity and complexity of these processes, it does not come as a surprise that Ca<sup>2+</sup>-release is controlled by a complex array of signaling pathways and second messengers [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. NAADP is the latest entry in the list of Ca<sup>2+</sup>-releasing molecules [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. This molecule is synthesized in the cell by ADP cyclases by exchanging the nicotinamide moiety of NADP with nicotinic acid [<xref ref-type="bibr" rid="CR21">21</xref>]. Notably, among all known Ca<sup>2+</sup>-releasing agents, NAADP is the most potent one acting in the low-nanomolar concentration range [<xref ref-type="bibr" rid="CR14">14</xref>]. The Ca<sup>2+</sup>-releasing activity of NAADP was first discovered in the mid-1990s in acidic lysosome-related organelles of sea urchin eggs [<xref ref-type="bibr" rid="CR20">20</xref>] and has since been demonstrated in many mammalian tissues and cell types [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. NAADP-mediated Ca<sup>2+</sup>-release is characterized by a number of characteristic features. First of all, NAADP-dependent Ca<sup>2+</sup>-release displays a characteristic bell-shaped dose-response curve with a peak in the low nanomolar concentration range and total loss of activity at high micromolar concentrations [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Moreover, the native NAADP-dependent Ca<sup>2+</sup>-release channel is insensitive to NADP which differs from NAADP only by the replacement of a carboxyl by an amid group [<xref ref-type="bibr" rid="CR15">15</xref>]. Finally, in contrast to IP<sub>3</sub>- and Ca<sup>2+</sup>/cADPR-sensitive stores, NAADP mainly seems to induce Ca<sup>2+</sup>-release from acidic lysosomal stores [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>], although in some cell types, NAADP-mediated Ca<sup>2+</sup>-release was also found in ER-derived stores, including the nuclear envelope [<xref ref-type="bibr" rid="CR15">15</xref>]</p><p>The molecular identity of the cellular NAADP receptor has been a matter of controversy [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. It was suggested that there may be no unique receptor for NAADP but that NAADP, like Ca<sup>2+</sup> and cADPR, is an agonist of the ryanodine receptor (RyR) complex present in ER-derived calcium stores [<xref ref-type="bibr" rid="CR15">15</xref>]. Other studies suggested that members of the transient receptor potential (TRP) channel family including TRPM2 [<xref ref-type="bibr" rid="CR1">1</xref>] and TRPML1 [<xref ref-type="bibr" rid="CR34">34</xref>] may be the cellular target protein of NAADP. However, the micromolar concentrations of NAADP required to fully activate these channel are one to two orders higher than those found for NAADP-mediated Ca<sup>2+</sup>-release in a variety of cells. Since none of the so-far analyzed proteins matches the hallmarks of native NAADP-sensitive release channels in a satisfying fashion, we hypothesized that the major receptor of NAADP may be formed by another not yet characterized protein.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><sec id="Sec3"><title>Cloning of TPCN1 and TPCN2</title><p>For cloning of TPCN1, two cDNA fragments were amplified from mouse brain RNA by RT-PCR using the SuperScript III-One-Step Kit (Invitrogen; primers for fragment 1: TTA GAA ATG CCT CTG ATG GAA and ATG CTT TGA GGT GAA ATT CCC A; primers for fragment 2: CAG ACA GCA TTG GTT TGA TGA G and GTG GGG TTT CTT CCT AGT GGT CTC GAG CCT CAT ACC AGA CAC AGA CAC). Following restriction digests, the two fragments were assembled in pcDNA3 using the Hind III site in the 5&#x02032; untranslated region, the central EcoR I site, and the Xho I site generated by PCR in the 3&#x02032; untranslated region (fragment 1&#x02009;=&#x02009;1,413&#x000a0;bp, fragment 2&#x02009;=&#x02009;1,548&#x000a0;bp). For cloning of TPCN2, the complete open-reading frame was amplified from mouse brain RNA. The forward primer (GGC TGT GGT ACC GCC ACC ATG GCG GCA GAA GAG CAG C) binds to the 5&#x02032; end and contains a Kozak consensus sequence and a Kpn I restriction site for cloning; the reverse Primer (GCC GCT CGA GAG GCC AGC ATC TCT GTC CTG) binds to the 3&#x02032; untranslated region and contains a Xho I restriction site for cloning. After restriction digest with KpnI and XhoI, the 2,255-bp fragment was cloned into pcDNA3 vector (Invitrogen). All cloned sequences were verified by sequencing.</p></sec><sec id="Sec4"><title>Northern blot</title><p>A mouse multiple tissue Northern blot (Applied Biosystems/Ambion, Austin, TX) containing 2&#x000a0;&#x000b5;g poly(A) RNA from heart, brain, liver, spleen, kidney, lung, thymus, testis, ovary, and embryo was hybridized with probes against TPCN1 and TPCN2. Probes covered the entire coding regions and were generated by random-primed labeling with a &#x003b1;<sup>32</sup>P-dCTP (Roche, Basel, Switzerland). The membrane was hybridized overnight in stringent conditions. After two washing steps, the hybridized probe was visualized with a phosphorimager after an exposure time of 24&#x000a0;h or using a film (Hyperfilm MP, GE Healthcare, Piscataway, NJ) after a radiographic exposure time of 14&#x000a0;days at &#x02013;80&#x000b0;C. The same blot was probed subsequently with TPCN1 and TPCN2 probes. The blot was stripped between each hybridization with SDS-containing buffer.</p></sec><sec id="Sec5"><title>Production of TPCN2-specific antibodies</title><p>Polyclonal rabbit antisera were raised against a peptide (CDILE EPKEE ELMEK LHKHP) corresponding to aa 707 to 725 of TPCN2 plus a N-terminal cystein. For affinity purification of antibodies, the peptide was coupled to SulfoLink Coupling Gel (Thermo Fisher Scientific, Walthan, USA) in a column. Serum was loaded onto column and washed. Bound antibodies were eluted with 100&#x000a0;mM Glycin-HCl pH 2.8 in 800&#x000a0;&#x000b5;l aliquots and immediately neutralized with Tris-base.</p></sec><sec id="Sec6"><title>Deglycosylation assay</title><p>The glycosylation deficient TPCN2 mutant (N594Q/N601Q) was cloned using the QuickChange Kit (Stratagene, La Jolla, CA). The deglycosylation assay was performed as described previously [<xref ref-type="bibr" rid="CR25">25</xref>]. Briefly, HEK293 cells were transfected with TPCN2, TPCN2N594Q/N601Q, or EGFP-TPCN1 using the calcium phosphate method and lysed; 10&#x000a0;&#x000b5;g of whole-cell lysates were incubated in the presence or absence of PNGase F or endoglycosidase H (both New England Biolabs, Ipswich, MA), according to the manufacturer&#x02019;s instruction. The protein denaturation was performed for 10&#x000a0;min at 45&#x000b0;C, the enzyme incubation for 1&#x000a0;h at 37&#x000b0;C. Cell lysates were then analyzed. Subsequently, proteins were subjected to Western blot analysis.</p></sec><sec id="Sec7"><title>Coimmunoprecipitation in HEK293 cells</title><p>For coimmunoprecipitation experiments, TPCN2 and TPCN1 fusion proteins were generated with either myc tag fused at the N-terminus or with EGFP sequence fused at the N-terminus. For expression of recombinant proteins, HEK293 cells were transfected using the calcium phosphate method. Three days after transfection, HEK293 cells were lysed as described previously [<xref ref-type="bibr" rid="CR30">30</xref>]. Equal amounts of protein (measured by Bradford assay) were incubated overnight at 4&#x000b0;C with 40&#x000a0;&#x000b5;l of protein A-Sepharose (GE Healthcare, Chalfont St. Giles, UK) and a specific antibody (Cell Signaling Technology, Beverly, MA) directed against the myc tag of examined proteins and 500&#x000a0;&#x000b5;l of buffer containing 50&#x000a0;mM Tris HCl (pH 7.4), 150&#x000a0;mM NaCl, 1&#x000a0;mM EDTA, and 50&#x000a0;mM Triton X-100, supplemented with PI. Beads were pelleted by centrifugation and washed three times with cold buffer containing 20&#x000a0;mM Tris HCl (pH 7.4), 5&#x000a0;mM MgCl<sub>2</sub>, 0.5&#x000a0;mM DTT, 20% (<italic>v</italic>/<italic>v</italic>) Glycerol supplemented with PI. Interacting proteins were visualized after boiling for 5&#x000a0;min in Laemmli sample buffer by SDS/PAGE, Western blot analysis, and ECL (GE Healthcare). The antibodies used were as follows: anti-GFP for detection of EGFP-TPCN2 fusion protein. An antibody against GST (GE Healthcare) was used as control.</p></sec><sec id="Sec8"><title>Immunocytochemistry</title><p>For immunodetection, COS-7 cells grown on glass coverslips in a 24-well plate were transiently transfected with TPCN2 cDNA using Fugene 6 (Roche Diagnostics). Cells were cultured in DMEM supplemented with 10% fetal calf serum and kept at 37&#x000b0;C, 10% CO<sub>2</sub> and fixed 1 or 2&#x000a0;days after transfection with 4% paraformaldehyde in PBS. Cells were permeabilized and blocked with 0.5% Triton X-100 and 5% Chemiblock (Millipore, Billerica, USA) in PBS. Cells were incubated with anti-TPCN2 (1:1000), anti-Myc (Cell Signaling, Danvers, MA; 1:1,000), anti-GFP (Clontech, Mountain View, USA; 1:500), anti-HA (Cell Signaling; 1:1000), anti-lamp1 (Abcam, Cambridge, USA; 1:250), and anti-Calnexin (Santa Cruz Biotechnology, Santa Cruz, USA; 1:100) primary antibodies in 2% Chemiblock (Millipore) and 0.3% Triton X-100 for 1&#x000a0;h. Then, cells were washed four times with PBS for 5&#x000a0;min each and incubated with AMCA (1:100), Cy2 (1:200), Cy3 (1:400), and Cy5 (1:400) secondary antibodies (all Jackson ImmunoResearch, West Grove, PA) in 2% Chemiblock (Millipore) for 1&#x000a0;h. Unbound antibodies were removed by three washing steps with PBS. For the staining of membranes and organelles, TRITC-WGA (membranes; 1:100; Sigma), Mitotracker Red CMX Ros (Mitochondria; 1:1,500; Invitrogen), and Hoechst 33342 (Nuclei; 0.4&#x000a0;&#x000b5;g/ml; Invitrogen) were used according to manufacturers&#x02019; instructions. For visualization of lysosomes, in some experiments, a lamp1-EGFP fusion protein was co-expressed with TPCN2 (kind gift of Esteban C. Dell'Angelica, Dept Human Genetics, UCLA, USA). The glass coverslips were then mounted onto glass slides with Permafluor (Sigma, St. Louis, MO). Cells were visualized under a Zeiss LSM 510 laser confocal microscope as previously described [<xref ref-type="bibr" rid="CR25">25</xref>].</p></sec><sec id="Sec9"><title>Cell surface expression</title><p>To determine surface expression of TPCN2 in COS-7 cells, the HA epitope was inserted into the loop between the putative first and second transmembrane domains of TPCN2. Two mutagenic primers (GTC GGG AAC ATC GTA TGG GTA AGT CTT TGT GAA GGA AGA TGG G and TAC GAT GTT CCC GAC TAC GCA GAT GTG CGC TAC CGT TC) have been used to insert the hemagglutinin sequence (YPYDVPDYA) in frame between amino acid residues 92 and 93 of TPCN2 using the QuikChange Kit (Stratagene) according to the manufacturer&#x02019;s instruction. The sequence has been verified by sequencing. After transfection, cells were analyzed by immunocytochemistry as described above except for omitting the permeabilization step with Triton X-100 (nonpermeabilized cells). Control cells were treated equally but permeabilized.</p></sec><sec id="Sec10"><title>Ca<sup>2+</sup> imaging</title><p>Two days after transfection with TPCN2-EGFP or with the empty EGFP vector using Fugene 6 (Roche, Basel, Switzerland), HEK293 cells were loaded with Fura-2AM (5&#x000a0;&#x000b5;M) before measuring [Ca<sup>2+</sup>]<sub>i</sub> and subsequently placed in extracellular recording solution containing (in mM) 140 NaCl, 5 KCl, 3 MgCl<sub>2</sub>, 10 glucose, and 10 HEPES, pH 7.4. The fluorescence intensity of individual patch-clamped cells was monitored with a dual excitation fluorometric system using a Carl Zeiss Axiovert 135 fluorescence microscope equipped with a &#x000d7;40 Plan-Apochromat 1.3 oil objective. The monochromatic light source (Polychrom II, TILL-Photonics) was tuned to excite Fura-2 fluorescence at 340&#x000a0;nm (F340) and 380&#x000a0;nm (F380) with a sampling frequency of 0.5&#x000a0;Hz for 3&#x000a0;ms each. Emission was detected at 450&#x02013;550&#x000a0;nm using a PCO SensiCam VGA camera (Kelheim, Germany) and recorded and analyzed using Tillvision (Till Photonics, Martinsried, Germany). For internal perfusion with NAADP, NADP, or IP<sub>3</sub>, Fura-2AM-loaded HEK293 cells were patched in standard whole-cell configuration. After establishing base line [Ca<sup>2+</sup>]<sub>i</sub>, the membrane was perforated, and the recording was continued in current clamp mode (<italic>I</italic>&#x02009;=&#x02009;0) [<xref ref-type="bibr" rid="CR4">4</xref>]. Patch pipette solution contained in mM&#x02014;140 KCl, 10 HEPES, 1 MgCl<sub>2</sub>, and 0.05 BAPTA (pH 7.4) [<xref ref-type="bibr" rid="CR6">6</xref>]. Fura-2 (pentapotassium salt, Invitrogen, Carlsbad, USA) was added to the standard internal solution at 7&#x000a0;&#x000b5;M in addition to preloading. Changes in Fura-2 fluorescence are reported as the fluorescence ratios (<italic>F</italic><sub>340</sub>/<italic>F</italic><sub>380</sub>) and are translated into apparent intracellular calcium concentration according to [<xref ref-type="bibr" rid="CR16">16</xref>].</p></sec><sec id="Sec11"><title>Statistics</title><p>All values are given as mean&#x02009;&#x000b1;&#x02009;SEM; <italic>n</italic> is the number of experiments. An unpaired <italic>t</italic> test was performed for the comparison between two groups. Significance was tested by ANOVA followed by Dunett test if multiple comparisons were made. Values of <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 were considered significant.</p></sec></sec><sec id="Sec12" sec-type="results"><title>Results</title><p>In our search for novel intracellular Ca<sup>2+</sup>-release channels, we analyzed mammalian homologs of the two-pore cation channel TPC1, a Ca<sup>2+</sup>-activated release channel identified in the vacuolar membrane of Arabidopsis thaliana and other plants [<xref ref-type="bibr" rid="CR26">26</xref>]. A rat homolog of TPC1, designated TPCN1 was originally cloned from rat kidney but was not functionally characterized [<xref ref-type="bibr" rid="CR18">18</xref>]. Based on sequence data from the gene bank, we cloned full-length murine TPCN1 and a novel homolog of this channel, TPCN2. Murine TPCN1 and TPCN2 show an overall sequence identity of about 20% to each other and to plant TPC1 [<xref ref-type="bibr" rid="CR26">26</xref>] (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>, Supplementary Fig. S<xref ref-type="supplementary-material" rid="MOESM1">1</xref>). TPCN channels represent a distinct branch within the superfamily of pore-loop channels [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. They are composed of two homologous building blocks each containing six transmembrane helices (S<xref ref-type="supplementary-material" rid="MOESM1">1</xref>&#x02013;S<xref ref-type="supplementary-material" rid="MOESM1">6</xref>) and an ion-conducting pore loop between S<xref ref-type="supplementary-material" rid="MOESM1">5</xref> and S<xref ref-type="supplementary-material" rid="MOESM1">6</xref>. The two putative pore loops of TPCN1 and TPCN2 show substantial homology to the pore of TPC1. In contrast to TPC1 both murine channels do not contain EF hand motifs that may act as Ca<sup>2+</sup> sensors in TPC1. Transcripts of TPCN1 and TPCN2 are widely expressed in the body (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>, Supplementary Figs. S<xref ref-type="supplementary-material" rid="MOESM1">2</xref>, S<xref ref-type="supplementary-material" rid="MOESM1">3</xref>) with expression levels of TPCN1 usually being higher than those of TPCN2 (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>, Supplementary Fig. S<xref ref-type="supplementary-material" rid="MOESM1">3</xref>). The size of the detected mRNA transcripts corresponds well to the size of the predicted sequence (4,705&#x000a0;bp for TPCN1 and 2,909&#x000a0;bp for TPCN2). Upon heterologous expression in HEK293 or COS-7 cells, both TPCN1 and TPCN2 are strictly localized in intracellular compartments (Figs.&#x000a0;<xref rid="Fig1" ref-type="fig">1c</xref>, <xref rid="Fig2" ref-type="fig">2</xref>). Removal of the cytosolic N- and C-termini, as well as deletion of cryptic ER retention signals [<xref ref-type="bibr" rid="CR33">33</xref>], present in the primary sequences of TPCN1 or TPCN2 (dileucine motifs starting at position 8 and 692 and a RxR motive starting at position 313 in TPCN2) did not result in increased expression in the plasma membrane (not shown). Two protein bands were detected in immunoblots for either TPCN1 or TPCN2 (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1d</xref>, left lanes in left and middle panels, see also Supplementary Fig. S<xref ref-type="supplementary-material" rid="MOESM1">4</xref> for generation and validation of the TPCN2 antibody). The respective lower bands represent the core-glycosylated proteins since they are shifted to slightly lower molecular weights after incubation with endo-glycosidase H (EndoH). The upper band corresponds to the fully glycosylated mature channel which is resistant to Endo H and is sensitive to treatment with N-glycosidase F (PNGase F). Mutation of the two putative N-glycosylation sites in TPCN2 (N594 and N601) resulted in the production of a non-glycosylated protein (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1d</xref>, right panel). The size of the non-glycosylated TPCN1 and TPCN2 proteins was smaller than predicted from the primary sequence (78.5 vs. 94.3&#x000a0;kDa for TPCN1 and 63 vs. 83.5&#x000a0;kDa for TPCN2). The apparent smaller molecular weight very likely arises from an aberrant gel mobility of the two proteins because it was also observed with EGFP-tagged TPCN channel proteins and with antibodies that were targeted to either N- or C-termini. Given the principal topology of pore-loop cation channels, it is very likely that two TPCN channel subunits assemble to form a complex with pseudo-tetrameric symmetry. Indeed, co-immunoprecipitation experiments showed that TPCN2 assembles with each other to form homomers (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1e</xref>). By contrast, TPCN2 did not form immunocomplexes with TPCN1 indicating that TPCN2&#x02013;TPCN1 heteromers are not formed in the cell (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1e</xref>). <fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Properties of two-pore channels. <bold>a</bold><italic>Upper panel</italic> Transmembrane topology of TPCN1 and TPCN2. The predicted N-glycosylation sites are marked by <italic>red forks</italic>. <italic>Lower panel</italic> Schematic representation of the primary sequence of TPCN1 and TPCN2. The degree of sequence identity within the N- and C-termini, the two transmembrane building blocks and the interdomain linker is indicated. <bold>b</bold> Mouse multiple tissue northern blots of TPCN1 (<italic>left panel</italic>) and TPCN2 (<italic>right panel</italic>) demonstrate expression in all tissues investigated. <bold>c</bold> EGFP-TPCN1 (<italic>upper panel</italic>) and EGFP-TPCN2 (<italic>lower panel</italic>) channels expressed in HEK293 cells are localized intracellularly (<italic>green</italic> TPCN channels; <italic>red</italic> membrane marker, <italic>blue</italic> nuclei; <italic>scale bar</italic> 5&#x000a0;&#x000b5;m). <bold>d</bold> Western blots with lysates from HEK293 cells containing myc-tagged TPCN1 (<italic>left panel</italic>), wild-type TPCN2 (<italic>middle</italic>) panel, and a glycosylation-deficient TPCN2 double-mutant (TPCN-2Q; <italic>right panel</italic>). Ten micrograms of protein were applied per lane. <bold>e</bold> Lysates of HEK293 cells cotransfected with myc-tagged TPCN2 and EGFP-tagged TPCN2 (<italic>lanes 1&#x02013;3</italic>) or myc-tagged TPCN1 and EGFP-tagged TPCN2 (<italic>lanes 6&#x02013;8</italic>) were immunoprecipitated with anti-myc antibody (<italic>lanes 2</italic>, <italic>5</italic>, <italic>7</italic>) or anti-GST (control, <italic>lanes 3 and 8</italic>), blotted and probed with anti-GFP. <italic>Lanes 1</italic>, <italic>6</italic> input, <italic>lane 4</italic> negative control</p></caption><graphic position="anchor" xlink:href="424_2009_690_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>TPCN2 is localized in the lysosomes. Immunocytochemistry of TPCN2 in COS-7 cells. <bold>a</bold> Strong TPCN2 staining (<italic>green</italic>) is observed in intracellular compartments. By contrast, TPCN2 is absent from the plasma membrane (visualized in <italic>red</italic> by a specific maker). <bold>b</bold> After permeabilization, HA-tagged TPCN2 is detected intracellularily. <bold>c</bold> HA-tagged TPCN2 is not detected in the membrane of non permeabilized cells. <bold>d&#x02013;f</bold> Colocalization of TPCN2 (<italic>green</italic>) and the ER marker protein calnexin (<italic>red</italic>). Most TPCN2-positive structures (<bold>d</bold>) costaine for endoplasmic reticulum (<bold>e</bold>), yielding yellow in the overlay (<bold>f</bold>). <bold>g&#x02013;i</bold> Colocalization of TPCN2 (<italic>green</italic>) and lamp1 (<italic>red</italic>). Most TPCN2-positive structures (<bold>g</bold>) costained for lysosomes (<bold>h</bold>), yielding yellow in the overlay (<bold>i</bold>). (<italic>bars</italic> 10&#x000a0;&#x000b5;m)</p></caption><graphic position="anchor" xlink:href="424_2009_690_Fig2_HTML" id="MO2"/></fig></p><p>We next analyzed the subcellular expression of heterologously expressed TPCN2 in COS-7 cells. Using wild-type TPCN2 (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a</xref>) and TPCN2 channels carrying a HA tag in the linker region between S<xref ref-type="supplementary-material" rid="MOESM1">1</xref> and S<xref ref-type="supplementary-material" rid="MOESM1">2</xref> (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b, c</xref>), we confirmed that the channel is expressed purely in intracellular compartments. Within the cell, TPCN2 was present in the ER (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2d&#x02013;f</xref>) and colocalized with the lysosomal-associated membrane protein 1 (lamp1) that is a specific marker for acidic lysosomes (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2g&#x02013;i</xref>, Supplementary Fig. S<xref ref-type="supplementary-material" rid="MOESM1">5</xref>). By contrast, there was no significant overlap of the TPCN2 signal with a mitochondrial marker (MitoTracker, Supplementary Fig. S<xref ref-type="supplementary-material" rid="MOESM1">6</xref>).</p><p>The presence of TPCN2 in the ER and in lysomomes suggested that the protein may be a candidate for the NAADP-sensitive release channel [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. In order to test this hypothesis, we measured calcium transients by using Fura-2 fluoresence in HEK293 cells (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Fluorescence was measured in the whole-cell patch-clamp configuration with a Ca<sup>2+</sup>-free extracellular solution to ensure that changes in fluorescence were due to intracellular release. Cells transfected with TPCN2 that was N-terminally fused with EGFP to monitor expression (Supplementary Fig. S<xref ref-type="supplementary-material" rid="MOESM1">4</xref>) showed a similar basal Ca<sup>2+</sup> concentration (62.9&#x02009;&#x000b1;&#x02009;21.4&#x000a0;nM; <italic>n</italic>&#x02009;=&#x02009;15) as control cells transfected with EGFP alone (50.6&#x02009;&#x000b1;&#x02009;19.5&#x000a0;nM; <italic>n</italic>&#x02009;=&#x02009;8). Intracellular application of 30&#x000a0;nM NAADP produced a robust Ca<sup>2+</sup> transient in TPCN2-transfected cells (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a, c</xref>). The peak Ca<sup>2+</sup> concentration was 292&#x02009;&#x000b1;&#x02009;54.9&#x000a0;nM (<italic>n</italic>&#x02009;=&#x02009;28) which is in excellent agreement with Ca<sup>2+</sup> concentrations obtained in native cells after stimulation by NAADP [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. By contrast, control cells transfected with EGFP did not respond to NAADP (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3b</xref>, upper trace). Moreover, a close structural homolog of NAADP, NADP [<xref ref-type="bibr" rid="CR15">15</xref>] did not yield a Ca<sup>2+</sup> transient in TPCN2-transfected cells (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3b</xref>, middle trace). Remarkably, cells transfected with a TPCN1-EGFP fusion protein displayed no NAADP-sensitive Ca<sup>2+</sup>-release (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). The dose&#x02013;response curve of TPCN2 for NAADP has the typical bell-shape described for the native mammalian release channel [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR22">22</xref>] (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3d</xref>). The channel starts to get activated in the low nanomolar range of NAADP, reaches a peak at about 30&#x000a0;nM and inactivated at higher concentrations of NAADP. At micromolar NAADP concentrations, the channel is totally inactive. <fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>NAADP triggers Ca<sup>2+</sup>-release in HEK293 cells transfected with TPCN2. Application of 30&#x000a0;nM NAADP via the patch pipette induces Ca<sup>2+</sup>-release from internal stores in cells transfected with TPCN2-EGFP (<bold>a</bold>) but not in cells transfected with EGFP alone (<bold>b</bold>, <italic>upper panel</italic>) or cells transfected with TPCN1-EGFP (<bold>b</bold>, <italic>lower panel</italic>). In cells transfected with TPCN2-EGFP, NADP (30&#x000a0;nM; negative control) did not induce Ca<sup>2+</sup>-release (<bold>b</bold>, <italic>middle panel</italic>). The <italic>arrows</italic> in <bold>a</bold>, <bold>b</bold> indicate the start of cell perfusion. <bold>c</bold> Population data for experiments performed in (<bold>a</bold>, <bold>b</bold>). <bold>d</bold> Dose&#x02013;response relationship of NAADP. All values are given as mean &#x000b1; SEM. Number of cells measured is indicated in <italic>brackets</italic> in (<bold>c</bold>) and (<bold>d</bold>)</p></caption><graphic position="anchor" xlink:href="424_2009_690_Fig3_HTML" id="MO3"/></fig></p><p>In HEK293 and COS-7 cells, TPCN2 was localized in the ER and the lyosomes. We tested from which of these compartments the observed Ca<sup>2+</sup>-release was originating. Preincubation of the cells with bafilomycin, a specific blocker of the vacuolar type-H<sup>+</sup> ATPase [<xref ref-type="bibr" rid="CR5">5</xref>], almost completely abolished NAADP-mediated Ca<sup>2+</sup>-release (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a, d</xref>). By contrast, when ER stores were depleted by preincubation with the Ca<sup>2+</sup>-ATPase inhibitor thapsigargin, NAADP-sensitive Ca<sup>2+</sup>-release was not significantly reduced (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4b, d</xref>). IP<sub>3</sub> which opens IP<sub>3</sub>Rs in the ER induced Ca<sup>2+</sup>-release in control cells but did not evoke Ca<sup>2+</sup> transients in thapsigargin-pretreated cells (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001), demonstrating that the ER is functionally intact in TPCN2 expressing cells (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4c, d</xref>). These findings indicate that the observed Ca<sup>2+</sup>-release in TPCN2 expressing cells arises from lysosomal stores while the channel in the ER is functionally silent. The reason for the lack of activity of the channel in the ER has to be determined. However, one may speculate that TPCN2 requires an acidic pH as present in the lysomes and/or the assembly with proteins specifically expressed in lysosomes to acquire biological activity. <fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>TPCN2 mediates NAADP-dependent Ca<sup>2+</sup>-release from lysosomes. <bold>a</bold> In HEK293 cells transfected with TPCN2-EGFP, preincubation (45&#x000a0;min) with 100&#x000a0;nM bafilomycin almost completely abolished NAADP (30&#x000a0;nM)-induced Ca<sup>2+</sup>-release (<italic>black line</italic>). <italic>Red line</italic> control without pretreatment. <bold>b</bold> In HEK293 cells transfected with TPCN2-EGFP, preincubation (15&#x000a0;min) with 1&#x000a0;&#x000b5;M thapsigargin did not reduce NAADP-sensitive Ca<sup>2+</sup>-release (<italic>black line</italic>). <italic>Red line</italic> same control as in (<bold>a</bold>). <bold>c</bold> Effect of thapsigargin (1&#x000a0;&#x000b5;M) on the IP3 (3&#x000a0;&#x000b5;M)-induced Ca<sup>2+</sup>-release. Experiments were performed either with (<italic>black line</italic>) or without (<italic>red line</italic>) thapsigargin preincubation (1&#x000a0;&#x000b5;M; 15&#x000a0;min). <italic>Arrows</italic> in (<bold>a&#x02013;c</bold>) indicate the start of cell perfusion. <bold>d</bold> Population data for experiments shown in (<bold>a&#x02013;c</bold>). Number of cells measured is indicated in <italic>brackets</italic>. <italic>Tg</italic> thapsigargin; <italic>Baf</italic> bafilomycin; <italic>IP3</italic> Inositol-1,4,5-trisphosphate. Fluorescent ratio were normalized for better comparison</p></caption><graphic position="anchor" xlink:href="424_2009_690_Fig4_HTML" id="MO4"/></fig></p></sec><sec id="Sec13" sec-type="discussion"><title>Discussion</title><p>Here, we show that TPCN2, a novel member of the two-pore cation channel family, displays the basic functional properties of the native NAADP-dependent Ca<sup>2+</sup>-release channel. TPCN2 transcripts are widely expressed in the body and have been found in all tissues and organs investigated. TPCN2 encodes a glycosylated 75&#x000a0;kD protein forming homomers. Given the principal transmembrane topology of pore-loop cation channels, it is very likely that two TPCN channel subunits assemble with each other to form a complex with pseudo-tetrameric symmetry. This finding is in principal agreement with the reported molecular mass of the NAADP receptor of approximately 120&#x000a0;kDa [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR9">9</xref>] that roughly corresponds to a TPCN2 dimer. The TPCN2 protein is specifically localized in intracellular compartments and is totally absent from the plasma membrane. Within the cells, the protein was present in acidic lysosomes and in the ER. Since our functional studies strongly indicate that only the lysosomal fraction of TPCN2 is sensitive to NAADP, the presence of TPCN2 in the ER probably reflects an overexpression phenomenon, as reported for other proteins, including ion channels [<xref ref-type="bibr" rid="CR27">27</xref>].</p><p>Several lines of evidence support the notion that TPCN2 is a key component of long-sought lysosomal NAADP receptor. First of all, TPCN2 is the first channel identified that responds to NAADP in the correct physiological concentration range (low nM) [<xref ref-type="bibr" rid="CR14">14</xref>]. Secondly, as described for native channels, TPCN2 is inactivated by micromolar NAADP concentrations [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Thirdly, the channel is insensitive to the NAADP homolog NADP [<xref ref-type="bibr" rid="CR15">15</xref>]. Also, the homologous TPCN1 channel is totally insensitive to NAADP. Fourthly, the increase in the intracellular Ca<sup>2+</sup> concentration in cells expressing TPCN2 was in the same range as described for native NAADP-release channels [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Fifthly, TPCN2 is localized in the acidic lysosomes, the subcelluar organelles where NAADP-dependent Ca<sup>2+</sup>-release was originally described [<xref ref-type="bibr" rid="CR10">10</xref>]. Importantly, TPCN2 activity is abolished by maneuvers that deplete the lysosomes [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>] indicating that the protein is fully operative in these organelles. By contrast, TPCN2 present in the ER was functionally silent. While we cannot exclude that TPCN2 requires assembly with another cellular protein to form a functional Ca<sup>2+</sup>-release channel, the simplest interpretation of our work is that TPCN2 itself forms the lysosomal NAADP-sensitive Ca<sup>2+</sup>-release channel. Further in vivo studies will be required to dissect the signaling cascades that control activation and modulation of TPCN2.</p></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><supplementary-material id="N0x1d53ba0N0x2fc0ae0" content-type="local-data"><p>Below is the link to the electronic supplementary material. </p><media xlink:href="424_2009_690_MOESM1_ESM.doc" id="MOESM1" mimetype="application" mime-subtype="msword"><label>Supplement 1</label><caption><p>(DOC 9495&#x000a0;kb)</p></caption></media></supplementary-material></sec></body><back><!-- WARNING: ArticleNote has not been converted --><ack><title>Acknowledgements</title><p>Lamp1-EGFP was a kind gift of Esteban C. Dell'Angelica (Dept Human Genetics, UCLA; USA). This work was supported by the Deutsche Forschungsgemeinschaft (DFG).</p><p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>A</given-names></name><name><surname>Kolisek</surname><given-names>M</given-names></name><name><surname>Bagley</surname><given-names>LA</given-names></name><name><surname>Fleig</surname><given-names>A</given-names></name><name><surname>Penner</surname><given-names>R</given-names></name></person-group><article-title>Nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose regulate TRPM2 channels in T lymphocytes</article-title><source>Faseb J</source><year>2006</year><volume>20</volume><fpage>962</fpage><lpage>964</lpage><pub-id pub-id-type="doi">10.1096/fj.05-5538fje</pub-id></citation><citation citation-type="display-unstructured">Beck A, Kolisek M, Bagley LA, Fleig A, Penner R (2006) Nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose regulate TRPM2 channels in T lymphocytes. Faseb J 20:962&#x02013;964 <pub-id pub-id-type="pmid">16585058</pub-id></citation></ref><ref id="CR2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname><given-names>G</given-names></name><name><surname>Dickinson</surname><given-names>G</given-names></name><name><surname>Parrington</surname><given-names>J</given-names></name><name><surname>Galione</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name></person-group><article-title>Solubilization of receptors for the novel Ca<sup>2+</sup>-mobilizing messenger, nicotinic acid adenine dinucleotide phosphate</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>43717</fpage><lpage>43723</lpage><pub-id pub-id-type="doi">10.1074/jbc.M203224200</pub-id></citation><citation citation-type="display-unstructured">Berridge G, Dickinson G, Parrington J, Galione A, Patel S (2002) Solubilization of receptors for the novel Ca2+-mobilizing messenger, nicotinic acid adenine dinucleotide phosphate. J Biol Chem 277:43717&#x02013;43723 <pub-id pub-id-type="pmid">12223470</pub-id></citation></ref><ref id="CR3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname><given-names>MJ</given-names></name><name><surname>Lipp</surname><given-names>P</given-names></name><name><surname>Bootman</surname><given-names>MD</given-names></name></person-group><article-title>The versatility and universality of calcium signalling</article-title><source>Nat Rev Mol Cell Biol</source><year>2000</year><volume>1</volume><fpage>11</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1038/35036035</pub-id></citation><citation citation-type="display-unstructured">Berridge MJ, Lipp P, Bootman MD (2000) The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1:11&#x02013;21 <pub-id pub-id-type="pmid">11413485</pub-id></citation></ref><ref id="CR4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boittin</surname><given-names>FX</given-names></name><name><surname>Galione</surname><given-names>A</given-names></name><name><surname>Evans</surname><given-names>AM</given-names></name></person-group><article-title>Nicotinic acid adenine dinucleotide phosphate mediates Ca<sup>2+</sup> signals and contraction in arterial smooth muscle via a two-pool mechanism</article-title><source>Circ Res</source><year>2002</year><volume>91</volume><fpage>1168</fpage><lpage>1175</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000047507.22487.85</pub-id></citation><citation citation-type="display-unstructured">Boittin FX, Galione A, Evans AM (2002) Nicotinic acid adenine dinucleotide phosphate mediates Ca2+ signals and contraction in arterial smooth muscle via a two-pool mechanism. Circ Res 91:1168&#x02013;1175 <pub-id pub-id-type="pmid">12480818</pub-id></citation></ref><ref id="CR5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowman</surname><given-names>EJ</given-names></name><name><surname>Siebers</surname><given-names>A</given-names></name><name><surname>Altendorf</surname><given-names>K</given-names></name></person-group><article-title>Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells</article-title><source>Proc Natl Acad Sci U S A</source><year>1988</year><volume>85</volume><fpage>7972</fpage><lpage>7976</lpage><pub-id pub-id-type="doi">10.1073/pnas.85.21.7972</pub-id></citation><citation citation-type="display-unstructured">Bowman EJ, Siebers A, Altendorf K (1988) Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A 85:7972&#x02013;7976 <pub-id pub-id-type="pmid">2973058</pub-id></citation></ref><ref id="CR6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Broad</surname><given-names>LM</given-names></name><name><surname>Armstrong</surname><given-names>DL</given-names></name><name><surname>Putney</surname><given-names>JW</given-names><suffix>Jr</suffix></name></person-group><article-title>Role of the inositol 1,4,5-trisphosphate receptor in Ca(2+) feedback inhibition of calcium release-activated calcium current (I(crac))</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>32881</fpage><lpage>32888</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.46.32881</pub-id></citation><citation citation-type="display-unstructured">Broad LM, Armstrong DL, Putney JW Jr (1999) Role of the inositol 1,4,5-trisphosphate receptor in Ca(2+) feedback inhibition of calcium release-activated calcium current (I(crac)). J Biol Chem 274:32881&#x02013;32888 <pub-id pub-id-type="pmid">10551852</pub-id></citation></ref><ref id="CR7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calcraft</surname><given-names>PJ</given-names></name><name><surname>Ruas</surname><given-names>M</given-names></name><name><surname>Pan</surname><given-names>Z</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Arredouani</surname><given-names>A</given-names></name><name><surname>Hao</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Rietdorf</surname><given-names>K</given-names></name><name><surname>Teboul</surname><given-names>L</given-names></name><name><surname>Chuang</surname><given-names>KT</given-names></name><name><surname>Lin</surname><given-names>P</given-names></name><name><surname>Xiao</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Wyatt</surname><given-names>CN</given-names></name><name><surname>Parrington</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>AM</given-names></name><name><surname>Galione</surname><given-names>A</given-names></name><name><surname>Zhu</surname><given-names>MX</given-names></name></person-group><article-title>NAADP mobilizes calcium from acidic organelles through two-pore channels</article-title><source>Nature</source><year>2009</year><volume>459</volume><fpage>596</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1038/nature08030</pub-id></citation><citation citation-type="display-unstructured">Calcraft PJ, Ruas M, Pan Z, Cheng X, Arredouani A, Hao X, Tang J, Rietdorf K, Teboul L, Chuang KT, Lin P, Xiao R, Wang C, Zhu Y, Lin Y, Wyatt CN, Parrington J, Ma J, Evans AM, Galione A, Zhu MX (2009) NAADP mobilizes calcium from acidic organelles through two-pore channels. Nature 459:596&#x02013;600 <pub-id pub-id-type="pmid">19387438</pub-id></citation></ref><ref id="CR8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cancela</surname><given-names>JM</given-names></name><name><surname>Churchill</surname><given-names>GC</given-names></name><name><surname>Galione</surname><given-names>A</given-names></name></person-group><article-title>Coordination of agonist-induced Ca<sup>2+</sup>-signalling patterns by NAADP in pancreatic acinar cells</article-title><source>Nature</source><year>1999</year><volume>398</volume><fpage>74</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1038/18032</pub-id></citation><citation citation-type="display-unstructured">Cancela JM, Churchill GC, Galione A (1999) Coordination of agonist-induced Ca2+-signalling patterns by NAADP in pancreatic acinar cells. Nature 398:74&#x02013;76 <pub-id pub-id-type="pmid">10078532</pub-id></citation></ref><ref id="CR9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Churamani</surname><given-names>D</given-names></name><name><surname>Dickinson</surname><given-names>GD</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name></person-group><article-title>NAADP binding to its target protein in sea urchin eggs requires phospholipids</article-title><source>Biochem J</source><year>2005</year><volume>386</volume><fpage>497</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1042/BJ20041990</pub-id></citation><citation citation-type="display-unstructured">Churamani D, Dickinson GD, Patel S (2005) NAADP binding to its target protein in sea urchin eggs requires phospholipids. Biochem J 386:497&#x02013;504 <pub-id pub-id-type="pmid">15610067</pub-id></citation></ref><ref id="CR10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Churchill</surname><given-names>GC</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>Thomas</surname><given-names>JM</given-names></name><name><surname>Genazzani</surname><given-names>AA</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Galione</surname><given-names>A</given-names></name></person-group><article-title>NAADP mobilizes Ca(2+) from reserve granules, lysosome-related organelles, in sea urchin eggs</article-title><source>Cell</source><year>2002</year><volume>111</volume><fpage>703</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(02)01082-6</pub-id></citation><citation citation-type="display-unstructured">Churchill GC, Okada Y, Thomas JM, Genazzani AA, Patel S, Galione A (2002) NAADP mobilizes Ca(2+) from reserve granules, lysosome-related organelles, in sea urchin eggs. Cell 111:703&#x02013;708 <pub-id pub-id-type="pmid">12464181</pub-id></citation></ref><ref id="CR11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clapham</surname><given-names>DE</given-names></name></person-group><article-title>Calcium signaling</article-title><source>Cell</source><year>2007</year><volume>131</volume><fpage>1047</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.11.028</pub-id></citation><citation citation-type="display-unstructured">Clapham DE (2007) Calcium signaling. Cell 131:1047&#x02013;1058 <pub-id pub-id-type="pmid">18083096</pub-id></citation></ref><ref id="CR12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clapham</surname><given-names>DE</given-names></name><name><surname>Garbers</surname><given-names>DL</given-names></name></person-group><article-title>International Union of Pharmacology. L. Nomenclature and structure-function relationships of CatSper and two-pore channels</article-title><source>Pharmacol Rev</source><year>2005</year><volume>57</volume><fpage>451</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1124/pr.57.4.7</pub-id></citation><citation citation-type="display-unstructured">Clapham DE, Garbers DL (2005) International Union of Pharmacology. L. Nomenclature and structure-function relationships of CatSper and two-pore channels. Pharmacol Rev 57:451&#x02013;454 <pub-id pub-id-type="pmid">16382101</pub-id></citation></ref><ref id="CR13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galione</surname><given-names>A</given-names></name><name><surname>Petersen</surname><given-names>OH</given-names></name></person-group><article-title>The NAADP receptor: new receptors or new regulation?</article-title><source>Mol Interv</source><year>2005</year><volume>5</volume><fpage>73</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1124/mi.5.2.4</pub-id></citation><citation citation-type="display-unstructured">Galione A, Petersen OH (2005) The NAADP receptor: new receptors or new regulation? Mol Interv 5:73&#x02013;79 <pub-id pub-id-type="pmid">15821155</pub-id></citation></ref><ref id="CR14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galione</surname><given-names>A</given-names></name><name><surname>Ruas</surname><given-names>M</given-names></name></person-group><article-title>NAADP receptors</article-title><source>Cell Calcium</source><year>2005</year><volume>38</volume><fpage>273</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1016/j.ceca.2005.06.031</pub-id></citation><citation citation-type="display-unstructured">Galione A, Ruas M (2005) NAADP receptors. Cell Calcium 38:273&#x02013;280 <pub-id pub-id-type="pmid">16111747</pub-id></citation></ref><ref id="CR15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gerasimenko</surname><given-names>JV</given-names></name><name><surname>Maruyama</surname><given-names>Y</given-names></name><name><surname>Yano</surname><given-names>K</given-names></name><name><surname>Dolman</surname><given-names>NJ</given-names></name><name><surname>Tepikin</surname><given-names>AV</given-names></name><name><surname>Petersen</surname><given-names>OH</given-names></name><name><surname>Gerasimenko</surname><given-names>OV</given-names></name></person-group><article-title>NAADP mobilizes Ca2+ from a thapsigargin-sensitive store in the nuclear envelope by activating ryanodine receptors</article-title><source>J Cell Biol</source><year>2003</year><volume>163</volume><fpage>271</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1083/jcb.200306134</pub-id></citation><citation citation-type="display-unstructured">Gerasimenko JV, Maruyama Y, Yano K, Dolman NJ, Tepikin AV, Petersen OH, Gerasimenko OV (2003) NAADP mobilizes Ca2+ from a thapsigargin-sensitive store in the nuclear envelope by activating ryanodine receptors. J Cell Biol 163:271&#x02013;282 <pub-id pub-id-type="pmid">14568993</pub-id></citation></ref><ref id="CR16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grynkiewicz</surname><given-names>G</given-names></name><name><surname>Poenie</surname><given-names>M</given-names></name><name><surname>Tsien</surname><given-names>RY</given-names></name></person-group><article-title>A new generation of Ca<sup>2+</sup> indicators with greatly improved fluorescence properties</article-title><source>J Biol Chem</source><year>1985</year><volume>260</volume><fpage>3440</fpage><lpage>3450</lpage></citation><citation citation-type="display-unstructured">Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440&#x02013;3450 <pub-id pub-id-type="pmid">3838314</pub-id></citation></ref><ref id="CR17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guse</surname><given-names>AH</given-names></name><name><surname>Lee</surname><given-names>HC</given-names></name></person-group><article-title>NAADP: a universal Ca<sup>2+</sup> trigger</article-title><source>Sci Signal</source><year>2008</year><volume>1</volume><fpage>re10</fpage><pub-id pub-id-type="doi">10.1126/scisignal.144re10</pub-id></citation><citation citation-type="display-unstructured">Guse AH, Lee HC (2008) NAADP: a universal Ca2+ trigger. Sci Signal 1:re10 <pub-id pub-id-type="pmid">18984909</pub-id></citation></ref><ref id="CR18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishibashi</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Imai</surname><given-names>M</given-names></name></person-group><article-title>Molecular cloning of a novel form (two-repeat) protein related to voltage-gated sodium and calcium channels</article-title><source>Biochem Biophys Res Commun</source><year>2000</year><volume>270</volume><fpage>370</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2000.2435</pub-id></citation><citation citation-type="display-unstructured">Ishibashi K, Suzuki M, Imai M (2000) Molecular cloning of a novel form (two-repeat) protein related to voltage-gated sodium and calcium channels. Biochem Biophys Res Commun 270:370&#x02013;376 <pub-id pub-id-type="pmid">10753632</pub-id></citation></ref><ref id="CR19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HC</given-names></name></person-group><article-title>Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers</article-title><source>Annu Rev Pharmacol Toxicol</source><year>2001</year><volume>41</volume><fpage>317</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1146/annurev.pharmtox.41.1.317</pub-id></citation><citation citation-type="display-unstructured">Lee HC (2001) Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers. Annu Rev Pharmacol Toxicol 41:317&#x02013;345 <pub-id pub-id-type="pmid">11264460</pub-id></citation></ref><ref id="CR20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HC</given-names></name><name><surname>Aarhus</surname><given-names>R</given-names></name></person-group><article-title>A derivative of NADP mobilizes calcium stores insensitive to inositol trisphosphate and cyclic ADP-ribose</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>2152</fpage><lpage>2157</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.5.2152</pub-id></citation><citation citation-type="display-unstructured">Lee HC, Aarhus R (1995) A derivative of NADP mobilizes calcium stores insensitive to inositol trisphosphate and cyclic ADP-ribose. J Biol Chem 270:2152&#x02013;2157 <pub-id pub-id-type="pmid">7836444</pub-id></citation></ref><ref id="CR21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malavasi</surname><given-names>F</given-names></name><name><surname>Deaglio</surname><given-names>S</given-names></name><name><surname>Funaro</surname><given-names>A</given-names></name><name><surname>Ferrero</surname><given-names>E</given-names></name><name><surname>Horenstein</surname><given-names>AL</given-names></name><name><surname>Ortolan</surname><given-names>E</given-names></name><name><surname>Vaisitti</surname><given-names>T</given-names></name><name><surname>Aydin</surname><given-names>S</given-names></name></person-group><article-title>Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology</article-title><source>Physiol Rev</source><year>2008</year><volume>88</volume><fpage>841</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.1152/physrev.00035.2007</pub-id></citation><citation citation-type="display-unstructured">Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein AL, Ortolan E, Vaisitti T, Aydin S (2008) Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev 88:841&#x02013;886 <pub-id pub-id-type="pmid">18626062</pub-id></citation></ref><ref id="CR22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Masgrau</surname><given-names>R</given-names></name><name><surname>Churchill</surname><given-names>GC</given-names></name><name><surname>Morgan</surname><given-names>AJ</given-names></name><name><surname>Ashcroft</surname><given-names>SJ</given-names></name><name><surname>Galione</surname><given-names>A</given-names></name></person-group><article-title>NAADP: a new second messenger for glucose-induced Ca2+ responses in clonal pancreatic beta cells</article-title><source>Curr Biol</source><year>2003</year><volume>13</volume><fpage>247</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(03)00041-1</pub-id></citation><citation citation-type="display-unstructured">Masgrau R, Churchill GC, Morgan AJ, Ashcroft SJ, Galione A (2003) NAADP: a new second messenger for glucose-induced Ca2+ responses in clonal pancreatic beta cells. Curr Biol 13:247&#x02013;251 <pub-id pub-id-type="pmid">12573222</pub-id></citation></ref><ref id="CR23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mikoshiba</surname><given-names>K</given-names></name></person-group><article-title>IP3 receptor/Ca<sup>2+</sup> channel: from discovery to new signaling concepts</article-title><source>J Neurochem</source><year>2007</year><volume>102</volume><fpage>1426</fpage><lpage>1446</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.04825.x</pub-id></citation><citation citation-type="display-unstructured">Mikoshiba K (2007) IP3 receptor/Ca2+ channel: from discovery to new signaling concepts. J Neurochem 102:1426&#x02013;1446 <pub-id pub-id-type="pmid">17697045</pub-id></citation></ref><ref id="CR24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>AJ</given-names></name><name><surname>Galione</surname><given-names>A</given-names></name></person-group><article-title>NAADP induces pH changes in the lumen of acidic Ca<sup>2+</sup> stores</article-title><source>Biochem J</source><year>2007</year><volume>402</volume><fpage>301</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1042/BJ20060759</pub-id></citation><citation citation-type="display-unstructured">Morgan AJ, Galione A (2007) NAADP induces pH changes in the lumen of acidic Ca2+ stores. Biochem J 402:301&#x02013;310 <pub-id pub-id-type="pmid">17117921</pub-id></citation></ref><ref id="CR25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Much</surname><given-names>B</given-names></name><name><surname>Wahl-Schott</surname><given-names>C</given-names></name><name><surname>Zong</surname><given-names>X</given-names></name><name><surname>Schneider</surname><given-names>A</given-names></name><name><surname>Baumann</surname><given-names>L</given-names></name><name><surname>Moosmang</surname><given-names>S</given-names></name><name><surname>Ludwig</surname><given-names>A</given-names></name><name><surname>Biel</surname><given-names>M</given-names></name></person-group><article-title>Role of subunit heteromerization and N-linked glycosylation in the formation of functional hyperpolarization-activated cyclic nucleotide-gated channels</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>43781</fpage><lpage>43786</lpage><pub-id pub-id-type="doi">10.1074/jbc.M306958200</pub-id></citation><citation citation-type="display-unstructured">Much B, Wahl-Schott C, Zong X, Schneider A, Baumann L, Moosmang S, Ludwig A, Biel M (2003) Role of subunit heteromerization and N-linked glycosylation in the formation of functional hyperpolarization-activated cyclic nucleotide-gated channels. J Biol Chem 278:43781&#x02013;43786 <pub-id pub-id-type="pmid">12928435</pub-id></citation></ref><ref id="CR26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peiter</surname><given-names>E</given-names></name><name><surname>Maathuis</surname><given-names>FJ</given-names></name><name><surname>Mills</surname><given-names>LN</given-names></name><name><surname>Knight</surname><given-names>H</given-names></name><name><surname>Pelloux</surname><given-names>J</given-names></name><name><surname>Hetherington</surname><given-names>AM</given-names></name><name><surname>Sanders</surname><given-names>D</given-names></name></person-group><article-title>The vacuolar Ca2+-activated channel TPC1 regulates germination and stomatal movement</article-title><source>Nature</source><year>2005</year><volume>434</volume><fpage>404</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1038/nature03381</pub-id></citation><citation citation-type="display-unstructured">Peiter E, Maathuis FJ, Mills LN, Knight H, Pelloux J, Hetherington AM, Sanders D (2005) The vacuolar Ca2+-activated channel TPC1 regulates germination and stomatal movement. Nature 434:404&#x02013;408 <pub-id pub-id-type="pmid">15772667</pub-id></citation></ref><ref id="CR27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schroeder</surname><given-names>BC</given-names></name><name><surname>Waldegger</surname><given-names>S</given-names></name><name><surname>Fehr</surname><given-names>S</given-names></name><name><surname>Bleich</surname><given-names>M</given-names></name><name><surname>Warth</surname><given-names>R</given-names></name><name><surname>Greger</surname><given-names>R</given-names></name><name><surname>Jentsch</surname><given-names>TJ</given-names></name></person-group><article-title>A constitutively open potassium channel formed by KCNQ1 and KCNE3</article-title><source>Nature</source><year>2000</year><volume>403</volume><fpage>196</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1038/35003200</pub-id></citation><citation citation-type="display-unstructured">Schroeder BC, Waldegger S, Fehr S, Bleich M, Warth R, Greger R, Jentsch TJ (2000) A constitutively open potassium channel formed by KCNQ1 and KCNE3. Nature 403:196&#x02013;199 <pub-id pub-id-type="pmid">10646604</pub-id></citation></ref><ref id="CR28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steen</surname><given-names>M</given-names></name><name><surname>Kirchberger</surname><given-names>T</given-names></name><name><surname>Guse</surname><given-names>AH</given-names></name></person-group><article-title>NAADP mobilizes calcium from the endoplasmic reticular Ca(2+) store in T-lymphocytes</article-title><source>J Biol Chem</source><year>2007</year><volume>282</volume><fpage>18864</fpage><lpage>18871</lpage><pub-id pub-id-type="doi">10.1074/jbc.M610925200</pub-id></citation><citation citation-type="display-unstructured">Steen M, Kirchberger T, Guse AH (2007) NAADP mobilizes calcium from the endoplasmic reticular Ca(2+) store in T-lymphocytes. J Biol Chem 282:18864&#x02013;18871 <pub-id pub-id-type="pmid">17446167</pub-id></citation></ref><ref id="CR29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Streb</surname><given-names>H</given-names></name><name><surname>Irvine</surname><given-names>RF</given-names></name><name><surname>Berridge</surname><given-names>MJ</given-names></name><name><surname>Schulz</surname><given-names>I</given-names></name></person-group><article-title>Release of Ca<sup>2+</sup> from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate</article-title><source>Nature</source><year>1983</year><volume>306</volume><fpage>67</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1038/306067a0</pub-id></citation><citation citation-type="display-unstructured">Streb H, Irvine RF, Berridge MJ, Schulz I (1983) Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 306:67&#x02013;69 <pub-id pub-id-type="pmid">6605482</pub-id></citation></ref><ref id="CR30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wahl-Schott</surname><given-names>C</given-names></name><name><surname>Baumann</surname><given-names>L</given-names></name><name><surname>Cuny</surname><given-names>H</given-names></name><name><surname>Eckert</surname><given-names>C</given-names></name><name><surname>Griessmeier</surname><given-names>K</given-names></name><name><surname>Biel</surname><given-names>M</given-names></name></person-group><article-title>Switching off calcium-dependent inactivation in L-type calcium channels by an autoinhibitory domain</article-title><source>Proc Natl Acad Sci U S A</source><year>2006</year><volume>103</volume><fpage>15657</fpage><lpage>15662</lpage><pub-id pub-id-type="doi">10.1073/pnas.0604621103</pub-id></citation><citation citation-type="display-unstructured">Wahl-Schott C, Baumann L, Cuny H, Eckert C, Griessmeier K, Biel M (2006) Switching off calcium-dependent inactivation in L-type calcium channels by an autoinhibitory domain. Proc Natl Acad Sci U S A 103:15657&#x02013;15662 <pub-id pub-id-type="pmid">17028172</pub-id></citation></ref><ref id="CR31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>FH</given-names></name><name><surname>Catterall</surname><given-names>WA</given-names></name></person-group><article-title>The VGL-chanome: a protein superfamily specialized for electrical signaling and ionic homeostasis</article-title><source>Sci STKE</source><year>2004</year><volume>2004</volume><fpage>15</fpage><pub-id pub-id-type="doi">10.1126/stke.2532004re15</pub-id></citation><citation citation-type="display-unstructured">Yu FH, Catterall WA (2004) The VGL-chanome: a protein superfamily specialized for electrical signaling and ionic homeostasis. Sci STKE 2004:15 </citation></ref><ref id="CR32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zalk</surname><given-names>R</given-names></name><name><surname>Lehnart</surname><given-names>SE</given-names></name><name><surname>Marks</surname><given-names>AR</given-names></name></person-group><article-title>Modulation of the ryanodine receptor and intracellular calcium</article-title><source>Annu Rev Biochem</source><year>2007</year><volume>76</volume><fpage>367</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.76.053105.094237</pub-id></citation><citation citation-type="display-unstructured">Zalk R, Lehnart SE, Marks AR (2007) Modulation of the ryanodine receptor and intracellular calcium. Annu Rev Biochem 76:367&#x02013;385 <pub-id pub-id-type="pmid">17506640</pub-id></citation></ref><ref id="CR33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zerangue</surname><given-names>N</given-names></name><name><surname>Schwappach</surname><given-names>B</given-names></name><name><surname>Jan</surname><given-names>YN</given-names></name><name><surname>Jan</surname><given-names>LY</given-names></name></person-group><article-title>A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels</article-title><source>Neuron</source><year>1999</year><volume>22</volume><fpage>537</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80708-4</pub-id></citation><citation citation-type="display-unstructured">Zerangue N, Schwappach B, Jan YN, Jan LY (1999) A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels. Neuron 22:537&#x02013;548 <pub-id pub-id-type="pmid">10197533</pub-id></citation></ref><ref id="CR34"><label>34.</label><citation citation-type="other">Zhang F, Jin S, Yi F, Li PL (2008) TRP-ML1 functions as a lysosomal NAADP-sensitive Ca(2+) release channel in coronary arterial myocytes. J Cell Mol Med. doi:10.1111/j.1582-4934.2008.00486.x</citation></ref></ref-list><fn-group><fn><p>Xiangang Zong and Michael Schieder contributed equally to this work.</p></fn><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (doi:10.1007/s00424-009-0690-y) contains supplementary material, which is available to authorized users.</p></fn><fn><p>Note added in proof: during the submission process<italic>,</italic> a paper was published presenting similar findings that TPCN2 mediates NAADP<italic>-</italic>dependent Ca<sup>2+</sup>-release from acidic organelles [<xref ref-type="bibr" rid="CR7">7</xref>].</p></fn></fn-group></back></article> 